Showing results (81-90 of 104) with videos related to
Sort By:
Pageof 11
Bulletin of the World Health Organization|February 12, 2013
Multidrug-resistant tuberculosis in Belarus: the size of the problem and associated risk factorsAlena Skrahina, Henadz Hurevich, Aksana Zalutskaya, et al.Journal of Clinical Microbiology|September 27, 2013
Rifampin heteroresistance in Mycobacterium tuberculosis cultures as detected by phenotypic and genotypic drug susceptibility test methodsDorte Bek Folkvardsen, Vibeke Ø Thomsen, Leen Rigouts, et al.Antimicrobial Agents and Chemotherapy|February 1, 2012
Antigen 85C inhibition restricts Mycobacterium tuberculosis growth through disruption of cord factor biosynthesisThulasi Warrier, Marielle Tropis, Jim Werngren, et al.Journal of Global Antimicrobial Resistance|January 11, 2019
Direct drug susceptibility testing of Mycobacterium tuberculosis using the proportional method: A multicenter studySirus Amini, Sven Hoffner, Mohammad Reza Allahyar Torkaman, et al.Plos One|February 10, 2011
Genomic stability over 9 years of an isoniazid resistant Mycobacterium tuberculosis outbreak strain in SwedenLinus Sandegren, Ramona Groenheit, Tuija Koivula, et al.Journal of Clinical Microbiology|October 1, 2010
Rifampin-isoniazid oligonucleotide typing: an alternative format for rapid detection of multidrug-resistant Mycobacterium tuberculosisIván Hernández-Neuta, Andrés Varela, Anandi Martin, et al.Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|August 31, 2015
Beijing clades of Mycobacterium tuberculosis are associated with differential survival in HIV-negative Russian patientsYanina Balabanova, Vladyslav Nikolayevskyy, Olga Ignatyeva, et al.The Journal of Antimicrobial Chemotherapy|March 12, 2011
Multicentre laboratory validation of the colorimetric redox indicator (CRI) assay for the rapid detection of extensively drug-resistant (XDR) Mycobacterium tuberculosisAnandi Martin, Fabienne Paasch, Sven Docx, et al.The Lancet. Infectious Diseases|November 20, 2019
Tuberculosis, HIV, and viral hepatitis diagnostics in eastern Europe and central Asia: high time for integrated and people-centred servicesMasoud Dara, Soudeh Ehsani, Antons Mozalevskis, et al.Lancet (London, England)|April 21, 2009
Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance SurveillanceAbigail Wright, Matteo Zignol, Armand Van Deun, et al.Pageof 11